Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,350.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 100.00 (1.887%)
Market Cap: £135.24m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Trading Update

6 Jun 2024 07:00

RNS Number : 3086R
Camellia PLC
06 June 2024
 

6 June 2024

Camellia Plc

(the "Company" or the "Group")

 

Trading update

 

 

 

Tea

India: Production in May in all regions has been severely affected by very dry weather which is also expected to impact yields in June. While there are some early signs that prices for Assam and Darjeeling teas may be improving, it is too early in the season to adjust our forecasts. In the face of a substantial tightening of regulations around the use of chemicals in the growing process, the India subsidiary companies have decided to materially reduce bought leaf production as a risk mitigation strategy.

 

Bangladesh: Following industry discussions with the Bangladesh Tea Board, a fair pricing mechanism is being developed with the objective of improving prices and margins for producers. Other initiatives to support the industry, are also under consideration by government. While these are positive developments they are at an early stage and the scale of impact is not clear. 

 

Kenya: Favourable weather meant crops in May were higher than expected. However, as mentioned in our annual report, significant stocks of tea have been building up in the Kenya industry over recent years. With the revised minimum pricing mechanism, these are now being released to the market for sale with a significantly bigger impact on tea prices in the last month than expected. It looks like these lower prices are likely to continue for the remainder of this year. There is no obvious catalyst for prices to improve and in fact they may further weaken. Estimating the scale of this and hence the impact on our prices is difficult at this early stage in the year. The strength of the Kenya shilling remains a headwind.

 

Malawi: Weaker prices in Kenya have also impacted Malawi tea demand with further softening of prices in this market too. Production volumes in Malawi remain in line with expectations. 

 

Other crops

Other crops are performing in line with the guidance previously given.

 

BF&M

As mentioned in the annual report, the disposal of our interest in BF&M to Argus Group has been more complex and the approval process more protracted than expected. While we are still confident the sale of our stake will go ahead, further delays in the regulatory approval process mean we now expect completion in the latter part of 2024. The sale of BF&M is expected to result in cash consideration of $100m payable to Camellia, before expenses.

 

Bardsley

Progress has been made in the closure of the Bardsley's operation. We have now exited the two major leases and negotiations with the remaining landlords are ongoing. Asset disposals are also underway and we are on track to conclude the winding up process before the end of the year.

 

We expect to report a reduced loss for the year from Bardsley in the range of £3.5-4.5 million (2023: Loss £15.6 million). This includes the trading loss as well as the estimated cost of exiting leases, impairments, closure costs and the results of asset disposals. We expect a net cash recovery from the closure of £4-5 million. It is expected that Bardsley will be accounted for as a 'Discontinued operation' in 2024. 

 

Outlook for the year for continuing operations

Forecasting the outcome for the year at this stage in the year is difficult, not least because the majority of our production and sales occurs in the second half of the year. That said, despite reduced tea production expectations in India and further reductions in tea prices in Kenya and Malawi we continue to expect revenue above that of 2023. However, the outlook for the adjusted loss before tax for continuing operations has worsened from our previous guidance and is now at between £10-12 million (2023: £2.5 million loss).

 

Camellia had net cash of £21.7 million and investment portfolios with a market value of £38.1 million at 31 March 2024.

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Byron Coombs, CEO

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

H/Advisors Maitland 

PR

William Clutterbuck 07785 292617

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDZGGVVKKGDZM
Date   Source Headline
6th Sep 20222:45 pmRNSInterim Report 2022 - Replacement
1st Sep 20224:00 pmRNSInterim Report 2022
1st Sep 20227:00 amRNSHalf-year Report
24th Aug 20227:00 amRNSTrading Update
1st Jul 202210:54 amRNSResults of Annual General Meeting - 30 June 2022
30th Jun 20227:00 amRNSBF&M Strategic Review
30th Jun 20227:00 amRNSAGM Trading Statement
9th Jun 202211:12 amRNSBoard Committee Changes
6th Jun 20225:22 pmRNSAnnual Report and Notice of AGM
31st May 20227:00 amRNSFinal Results
6th May 20227:00 amRNSDirector Changes and Trading Update
22nd Dec 20217:00 amRNSTrading Update
17th Nov 20217:00 amRNS100% Ownership of Bardsley England
2nd Nov 20217:00 amRNSDirectorate Change
2nd Sep 20212:36 pmRNSInterim Report 2021
2nd Sep 20217:00 amRNSHalf-year Report and changes to Board Committees
25th Aug 202112:42 pmRNSNotice of Interim Results
6th Aug 20218:30 amRNSDeath of Director
5th Aug 20217:00 amRNSSale of Abbey Metal Finishing
2nd Aug 20217:00 amRNSPurchase of Bardsley England
20th Jul 20212:00 pmRNSTrading Update
3rd Jun 20214:15 pmRNSResults of Annual General Meeting - 3 June 2021
3rd Jun 202112:00 pmRNSAGM Trading Statement
5th May 20214:00 pmRNSAnnual Report and Notice of AGM
4th May 20217:00 amRNSFinal Results and Directorate change
29th Apr 20214:30 pmRNSFinal Results - Date of Announcement
11th Feb 20218:00 amRNSTrading update and settlement of claims
16th Nov 20207:00 amRNSCompletion of asset disposal
2nd Nov 20207:15 amRNSGovernance changes
21st Oct 20204:04 pmRNSTrading update
12th Oct 20207:00 amRNSResponse to UK media reports on Kakuzi Plc
8th Oct 20205:15 pmRNSUpdate on African allegations
7th Oct 202011:00 amRNSDirector/PDMR Shareholding
25th Sep 20209:58 amRNSInterim Report 2020
25th Sep 20207:00 amRNSHalf-year Report
15th Sep 202010:53 amRNSNotice of Interim Results
17th Aug 20201:55 pmRNSAsset Disposal Amendment
17th Aug 202011:17 amRNSAsset Disposal
10th Jun 20201:03 pmRNSCorrection to Result of AGM
10th Jun 202012:24 pmRNSResult of AGM
10th Jun 202011:30 amRNSAGM Trading Statement
15th May 202011:00 amRNSAnnual Report and Notice of Annual General Meeting
7th May 20203:18 pmRNSFinal Results
27th Apr 20207:00 amRNSTrading update
1st Apr 202012:00 pmRNSTrading update
26th Mar 20204:37 pmRNSPrice Monitoring Extension
6th Mar 20207:00 amRNSDirectorate Changes
21st Jan 20207:00 amRNSTrading Update
15th Aug 201910:51 amRNSInterim Report 2019
15th Aug 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.